Clinical Markers of Panic and Generalized Anxiety Disorder
- Conditions
- Generalized Anxiety DisorderPanic DisorderDuration of Untreated Illness
- Interventions
- Diagnostic Test: Structured Clinical Interview for DSM-5
- Registration Number
- NCT06071819
- Lead Sponsor
- University of Milano Bicocca
- Brief Summary
The goal of this observational study is to compare socio-demographic and clinical features in patients affected by Generalized Anxiety Disorder (GAD) and by Panic Disorder (PD). The main questions it aims to answer are:
* which socio-demographic/clinical markers are associated to GAD or PD diagnosis?
* which factors are associated with a longer duration of untreated illness (DUI) in GAD and in PD? Participants will signed a written informed consent and socio-demographic/clinical variables will be retrospectively collected. Researchers will compare GAD and PD groups in terms of socio-demographic and clinical features, including DUI, to better characterize the two disorders and to investigate factors associated to a longer DUI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 290
- age 18-65 years;
- ability and willing to give informed consent;
- fluency in Italian language;
- diagnosis of GAD or PD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, 5th edition.
- intellectual disability;
- lack of clinical and socio-demographic information;
- patients treated for less than three months in the outpatient clinics for the impossibility of a comprehensive collection of clinical variables.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Panic Disorder (PD) Structured Clinical Interview for DSM-5 Patients affected by Panic Disorder Generalized Anxiety Disorder (GAD) Structured Clinical Interview for DSM-5 Patients affected by GAD
- Primary Outcome Measures
Name Time Method Occupation Three months Occupation (employed/unemployed)
Treatment Three months Treatment, treatment discontinuation and side effects
Sex Three months Sex (male/female)
Substance misuse Three months Substance misuse
Dichotomous socio-demographic / clinical variables Three months Multiple family history of psychiatric disorders (yes/no), pre- and post-onset psychiatric poly-comorbidities (yes/no), presence of personality disorder (yes/no), pre- and post-onset poly-substance misuse (yes/no), pre- and post-onset medical poly-comorbidities (yes/no), suicide attempts (yes/no), hospitalizations (yes/no), poly-therapy (yes/no), presence of poly-side effects (yes/no), presence of lifetime psychotherapy (yes/no)
Quantitative socio-demographic / clinical variables Three months Age (years), age at onset (years), duration of illness (years), duration of treatment (years)
Pre-/post-onset Comorbidity Three months Psychiatric and medical comorbidity
- Secondary Outcome Measures
Name Time Method Duration of untreated illness (DUI) in months = time between the onset of PD and the first appropriate pharmacological treatment. Three months Factors associated to DUI among GAD and PD groups. Information about DUI have been registered according to what the patient reported (clinical records and structured interviews)
Trial Locations
- Locations (1)
University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori
🇮🇹Monza, MB, Italy